The company's high debt and significant deficit relative to its market cap of CN¥12.3b is worrisome. Shareholders could face heavy dilution if urgent balance sheet reinforcement is needed. Negative EBIT and revenue shrinkage over the past year further question its financial health, making it a risky stock.